公司问答丨博瑞医药：吸入用布地奈德混悬液已经获得药品注册证书

Group 1 - The core point of the article is that Borui Pharmaceutical has received a drug registration certificate for its inhaled Budesonide suspension, indicating progress in its approval process [1] Group 2 - Investors inquired about the approval status of Budesonide on an interactive platform [1] - Borui Pharmaceutical confirmed the approval and mentioned that detailed information can be found in the company's Q3 2025 report [1]